Health and Science / Policy
Trump Administration Announces Deals to Cut Obesity Drug Prices
The Trump administration has announced landmark deals with Eli Lilly and Novo Nordisk to significantly reduce the prices of some obesity drugs, aiming to expand access to these costly treatments. The agreements will affect Medicare and Medi...